Skip to main content
DT&CRO CO., Ltd. logo

DT&CRO CO., Ltd. — Investor Relations & Filings

Ticker · 383930 ISIN · KR7383930005 KO Professional, scientific and technical activities
Filings indexed 158 across all filing types
Latest filing 2025-03-13 AGM Information
Country KR South Korea
Listing KO 383930

About DT&CRO CO., Ltd.

http://www.dtncro.com/en/main/

DT&CRO CO., Ltd. is a full-service Contract Research Organization (CRO) that provides a comprehensive series of commissioned studies for the biopharmaceutical, chemical, functional food, and cosmetics sectors. The company's services span the entire development lifecycle, from non-clinical research, including GLP toxicity, pharmacokinetics (PK), and efficacy tests, to clinical trials, analysis, and regulatory consulting. Specialized offerings include a full-package service for FDA IND and NDA submissions, developed in partnership with Radyus Research. DT&CRO also provides an in-house SEND (Standard for Exchange of Nonclinical Data) program to streamline FDA registration and approval. Additionally, the company offers MoPS, a proprietary IT program that enables sponsors to manage projects and communicate with specialists in real-time.

Recent filings

Filing Released Lang Actions
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing submitted by DT&CRO regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company is holding its annual general meeting on a date designated as a 'concentrated date' by the KOSDAQ Association, citing audit schedules and financial reporting timelines. As this is a specific regulatory disclosure regarding meeting logistics rather than the meeting materials themselves, proxy solicitation, or voting results, it falls under the general regulatory filing category.
2025-03-13 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for (주)디티앤씨알오. It contains the agenda for the upcoming Annual General Meeting (AGM), including reports on audit, business operations, and internal accounting, as well as specific proposals for shareholder voting (e.g., approval of financial statements, appointment of directors). It also includes detailed management information and financial statements as part of the 'Management Reference' (경영참고사항) required for the meeting. This document is the primary material provided to shareholders to inform them of the meeting and the items to be voted upon, which fits the definition of Proxy Solicitation & Information Statement.
2025-03-13 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (often filed under the Financial Supervisory Service's DART system) used to solicit shareholder votes for an upcoming Annual General Meeting. It contains specific agenda items such as approval of financial statements, election of directors and auditors, and remuneration limits. This falls under the category of Proxy Solicitation & Information Statement.
2025-03-13 Korean
임원ㆍ주요주주특정증권등거래계획보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Trading Plan for Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 거래계획보고서) filed with the Korean financial authorities (Financial Supervisory Service/Korea Exchange). This is a specific regulatory filing required under South Korean capital market laws when insiders or major shareholders plan to trade their company's securities. Since it does not fit into the other specific categories like 'Director's Dealing' (which usually refers to completed trades) or 'Major Shareholding Notification' (which refers to threshold changes), it falls under the general regulatory filing category.
2025-02-13 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (DT&CRO) announcing a significant change (over 30%) in revenue or profit structure. This is a standard disclosure requirement in the Korean stock market (KRX) for listed companies to report preliminary financial results or material changes in financial structure before the final audit report is finalized. Since it provides key financial highlights and performance metrics rather than being a full annual report or a simple announcement of a report's availability, it falls under the 'Earnings Release' category. FY 2024
2025-02-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share transactions (specifically '장내매도' or on-market sales) of an executive (Seol Jung Won) of the company DT&CRO. This type of filing is a standard regulatory requirement for insider trading/shareholding changes by directors and executives, which corresponds to the 'Director's Dealing' category.
2024-12-26 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.